SCOPUS 정보 검색 플랫폼

Anticancer Research

Volumn 18, Issue 4 C, 1998, Pages 2989-2991

Clonal variability of radiation-induced cisplatin resistant HeLa cells

(2) Eichholtz Wirth, H a Marx, K b

a INSTITUTE OF EPIDEMIOLOGY (Germany)

b Flow Cytometry Group (Germany)

Author keywords

Apoptosis; CD95; Cisplatin resistance; Irradiation; NF B I B

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; DRUG RESISTANCE; GAMMA IRRADIATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION INJURY;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; CISPLATIN; CLONE CELLS; DRUG RESISTANCE, NEOPLASM; GAMMA RAYS; HELA CELLS; HUMANS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; RADIATION-SENSITIZING AGENTS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 0031866352 PISSN: 02507005 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (10)

References (9)

1
- 0029065720
- Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent antiapoptotic program
- Debatin K-M, Krammer PH: Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent antiapoptotic program. Leukemia 9: 815-820, 1995.
- (1995) Leukemia , vol.9 , pp. 815-820
- Debatin, K.-M.¹ Krammer, P.H.²

2
- 0030667735
- Reduced expression of the ICE-related protease CPP32 is associated with radiation-induced cisplatin resistance
- Eichholtz-Wirth H, Stötzer O, Marx K: Reduced expression of the ICE-related protease CPP32 is associated with radiation-induced cisplatin resistance. Br J Cancer 76: 1322-1327, 1997b.
- (1997) Br J Cancer , vol.76 , pp. 1322-1327
- Eichholtz-Wirth, H.¹ Stötzer, O.² Marx, K.³

3
- 0028025563
- Apoptosis in Cancer Therapy: Crossing the Threshold
- Fisher DE: Apoptosis in Cancer Therapy: Crossing the Threshold. Cell 78: 539-542, 1994.
- (1994) Cell , vol.78 , pp. 539-542
- Fisher, D.E.¹

4
- 0030656234
- Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells
- Friesen C, Fulda S, Debatin KM: Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia 11: 1833-1841, 1997.
- (1997) Leukemia , vol.11 , pp. 1833-1841
- Friesen, C.¹ Fulda, S.² Debatin, K.M.³

5
- 0030752603
- The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
- Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM: The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57: 3923-3829, 1997.
- (1997) Cancer Res , vol.57 , pp. 3923-13829
- Fulda, S.¹ Sieverts, H.² Friesen, C.³ Herr, I.⁴ Debatin, K.M.⁵

6
- 0030892234
- Apoptosis by death factors
- Nagata S: Apoptosis by death factors. Cell 88: 355-365, 1997.
- (1997) Cell , vol.88 , pp. 355-365
- Nagata, S.¹

7
- 0029992609
- Suppression of TNF-α-induced apoptosis by NFKB
- Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NFKB. Science 274: 787-789, 1996.
- (1996) Science , vol.274 , pp. 787-789
- Van Antwerp, D.J.¹ Martin, S.J.² Kafri, T.³ Green, D.R.⁴ Verma, I.M.⁵

8
- 0028971289
- Rel/NFκB/IκB family: Intimate tales of association and dissociation
- Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NFκB/IκB family: intimate tales of association and dissociation. Genes and Development 9: 2723-2735, 1995.
- (1995) Genes and Development , vol.9 , pp. 2723-2735
- Verma, I.M.¹ Stevenson, J.K.² Schwarz, E.M.³ Van Antwerp, D.⁴ Miyamoto, S.⁵

9
- 0029858387
- TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NFκB
- Wang C-Y, Marty WM, Baldwin AS: TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NFκB. Science 274: 784-787, 1996.
- (1996) Science , vol.274 , pp. 784-787
- Wang, C.-Y.¹ Marty, W.M.² Baldwin, A.S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.